Skip to main content
TipRanks
Go Ultimate75% OFF

ImmunityBio (26CA) Q1 2021 Earnings Report

19 Followers

DE:26CA Q1 2021 EPS Results

Actual EPS
-EUR 0.19
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.17

DE:26CA Q1 2021 Revenue Results

Actual Revenue
EUR 125.65K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q1 2021
Date
05/14/2021
Time
TBA
Conference Call
Friday, May 14, 2021
DE:26CA Upcoming Earnings

ImmunityBio's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q1 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:26CA Earnings History

DE:26CA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)-0.12--0.05――
Nov 09, 20262026 (Q3)-0.06-0.16-0.06-157.14% (-0.10)
Aug 04, 20262026 (Q2)-0.07-0.20-0.09-120.00% (-0.11)
May 07, 20262026 (Q1)-0.06-0.56-0.14-313.33% (-0.42)
Mar 03, 20262025 (Q4)-0.07-0.05-0.0833.33% (+0.03)
Nov 04, 20252025 (Q3)-0.10-0.06-0.1350.00% (+0.06)
Aug 05, 20252025 (Q2)-0.10-0.09-0.1850.00% (+0.09)
May 12, 20252025 (Q1)-0.12-0.14-0.1825.00% (+0.05)
Mar 03, 20252024 (Q4)-0.18-0.08-0.3375.00% (+0.24)
Nov 12, 20242024 (Q3)-0.16-0.13-0.1726.32% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed